Neuroendocrine tumors PET: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) Created page with "test" |
Matt Pijoan (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Neuroendocrine tumors}} | |||
{{CMG}} | |||
== Overview == | |||
==PET-CT Scan== | |||
A [[gallium]]-68 receptor [[positron emission tomography|PET]]-CT, integrating a PET image with a CT image, is much more senstitive than an OctreoScan, and it generates objective (quantified) results in the form of a standardized uptake value (SUV). | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:Oncology]] | |||
[[Category:Endocrinology]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 20:04, 10 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
|
Neuroendocrine tumors Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
PET-CT Scan
A gallium-68 receptor PET-CT, integrating a PET image with a CT image, is much more senstitive than an OctreoScan, and it generates objective (quantified) results in the form of a standardized uptake value (SUV).